BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37683624)

  • 1. Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results.
    Zwijsen K; Schillebeeckx E; Janssens E; Cleemput JV; Richart T; Surmont VF; Nackaerts K; Marcq E; van Meerbeeck JP; Lamote K
    J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37683624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS).
    Lamote K; Vynck M; Van Cleemput J; Thas O; Nackaerts K; van Meerbeeck JP
    J Breath Res; 2016 Sep; 10(4):046001. PubMed ID: 27669062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled breath to screen for malignant pleural mesothelioma: a validation study.
    Lamote K; Vynck M; Thas O; Van Cleemput J; Nackaerts K; van Meerbeeck JP
    Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29269578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
    Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
    Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.
    Roberts HC; Patsios DA; Paul NS; DePerrot M; Teel W; Bayanati H; Shepherd F; Johnston MR
    J Thorac Oncol; 2009 May; 4(5):620-8. PubMed ID: 19357540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study.
    Lamote K; Brinkman P; Vandermeersch L; Vynck M; Sterk PJ; Van Langenhove H; Thas O; Van Cleemput J; Nackaerts K; van Meerbeeck JP
    Oncotarget; 2017 Oct; 8(53):91593-91602. PubMed ID: 29207669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review.
    Töreyin ZN; Ghosh M; Göksel Ö; Göksel T; Godderis L
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32050546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma.
    Janssens E; Schillebeeckx E; Zwijsen K; Raskin J; Van Cleemput J; Surmont VF; Nackaerts K; Marcq E; van Meerbeeck JP; Lamote K
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
    Dragonieri S; van der Schee MP; Massaro T; Schiavulli N; Brinkman P; Pinca A; Carratú P; Spanevello A; Resta O; Musti M; Sterk PJ
    Lung Cancer; 2012 Mar; 75(3):326-31. PubMed ID: 21924516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleural plaques and the risk of pleural mesothelioma.
    Pairon JC; Laurent F; Rinaldo M; Clin B; Andujar P; Ameille J; Brochard P; Chammings S; Ferretti G; Galateau-Sallé F; Gislard A; Letourneux M; Luc A; Schorlé E; Paris C
    J Natl Cancer Inst; 2013 Feb; 105(4):293-301. PubMed ID: 23355760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.
    Di Gilio A; Catino A; Lombardi A; Palmisani J; Facchini L; Mongelli T; Varesano N; Bellotti R; Galetta D; de Gennaro G; Tangaro S
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients.
    Sahin AA; Cöplü L; Selçuk ZT; Eryilmaz M; Emri S; Akhan O; Bariş YI
    AJR Am J Roentgenol; 1993 Sep; 161(3):533-7. PubMed ID: 8394641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic.
    Jakubec P; Pelclova D; Smolkova P; Kolek V; Nakladalova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):472-9. PubMed ID: 24781044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesis.
    Lamote K; Nackaerts K; van Meerbeeck JP
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):898-908. PubMed ID: 24706728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium scanning in differentiating malignant from benign asbestos-related pleural disease.
    Teirstein AS; Chahinian P; Goldsmith SJ; Sorek M
    Am J Ind Med; 1986; 9(5):487-94. PubMed ID: 3717172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-time-response association between occupational asbestos exposure and pleural mesothelioma.
    Lacourt A; Lévêque E; Guichard E; Gilg Soit Ilg A; Sylvestre MP; Leffondré K
    Occup Environ Med; 2017 Sep; 74(9):691-697. PubMed ID: 28501798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure.
    de Gennaro G; Dragonieri S; Longobardi F; Musti M; Stallone G; Trizio L; Tutino M
    Anal Bioanal Chem; 2010 Dec; 398(7-8):3043-50. PubMed ID: 20924566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up of subjects occupationally exposed to asbestos, what are the objectives, the benefits, and the possible risks?].
    Dalphin JC
    Rev Mal Respir; 2011 Dec; 28(10):1230-40. PubMed ID: 22152932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of screening for malignant pleural mesothelioma.
    Pass HI; Carbone M
    Semin Thorac Cardiovasc Surg; 2009; 21(2):97-104. PubMed ID: 19822280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.